Andrew O. Zheltukhin is a molecular biologist at the Russian Academy of Sciences, Institute of Molecular Biology in Moscow. His research spans cancer biology, virotherapy, and ageing. He has co-authored 12 scientific publications with over 2,000 reads and 180 citations. Zheltukhin has investigated oncolytic enteroviruses as potential cancer treatments, the role of stress-responsive proteins like Sestrins in metabolism, and regulatory mechanisms of tumour suppressors such as p53. His work often intersects with collaborators including Peter Chumakov and Andrei Budanov. Through studies in C. elegans, cancer cell models, and viral therapies, Zheltukhin contributes to advancing strategies against ageing and cancer.